Preclinical data and mode of action of amorolfine
- 1 September 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 17 (s1), 8-12
- https://doi.org/10.1111/j.1365-2230.1992.tb00270.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- AmorolfinePublished by Springer Science and Business Media LLC ,1990
- In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivativeMycopathologia, 1987
- Inhibitory Effect of Antifungal Agents on Germ Tube Formation in Candida albicans. Hemmeffekt antifungaler Wirkstoffe auf die Keimschlauchbildung von Candida albicansMycoses, 1987
- Antifungal relative inhibition factors: BAY 1–9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14–4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agentsJournal of Antimicrobial Chemotherapy, 1984
- In vitro studies with R 51,211 (itraconazole)Antimicrobial Agents and Chemotherapy, 1984
- Antifungal activity of four antifungal drugs in the cutaneous retention time testMedical Mycology, 1984
- In-vitro studies with four new antifungal agents: BAY n7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002Medical Mycology, 1984
- Relative inhibition factors—a novel approach to the assessment of antifunga antibiotics in vitroJournal of Antimicrobial Chemotherapy, 1984
- Antifungal activityin vitroof Ro 14-4767/002, a phenylpropyl-morpholineMedical Mycology, 1983
- Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importanceJournal of Antimicrobial Chemotherapy, 1980